Esperion Therapeutics News

BofA Securities Maintains Esperion Therapeutics(ESPR.US) With Sell Rating

Moomoo NewsOct 28 10:31 ET

Esperion Therapeutics Analyst Ratings

BenzingaOct 2 10:48 ET

H.C. Wainwright Maintains Esperion Therapeutics(ESPR.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsOct 2 10:33 ET

JMP Securities Maintains Esperion Therapeutics(ESPR.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsSep 3 11:32 ET

Esperion Therapeutics Analyst Ratings

BenzingaAug 12 13:55 ET

BofA Securities Maintains Esperion Therapeutics(ESPR.US) With Sell Rating

Moomoo NewsJul 30 09:51 ET

Esperion Therapeutics Analyst Ratings

BenzingaJun 28 11:08 ET

Esperion Therapeutics Analyst Ratings

BenzingaJun 20 06:37 ET

Esperion Therapeutics Analyst Ratings

BenzingaMay 22 12:03 ET

Esperion Therapeutics Analyst Ratings

BenzingaMay 21 05:42 ET

HC Wainwright & Co. Reiterates Buy on Esperion Therapeutics, Maintains $16 Price Target

BenzingaMay 8 09:34 ET

Esperion Therapeutics Analyst Ratings

BenzingaApr 10 06:51 ET

Northland Securities Sticks to Their Hold Rating for Esperion (ESPR)

TipRanksMar 25 09:01 ET

Esperion Therapeutics Analyst Ratings

BenzingaMar 25 07:37 ET

Esperion Therapeutics Analyst Ratings

BenzingaFeb 27 14:46 ET

Esperion Therapeutics Analyst Ratings

BenzingaNov 20, 2023 08:25 ET

Esperion Therapeutics Analyst Ratings

BenzingaNov 13, 2023 11:17 ET

Needham Maintains Buy on Esperion Therapeutics, Lowers Price Target to $8

BenzingaNov 7, 2023 15:29 ET

Esperion Therapeutics Analyst Ratings

BenzingaNov 7, 2023 15:28 ET

Needham Reiterates Buy on Esperion Therapeutics, Maintains $9 Price Target

BenzingaOct 2, 2023 06:31 ET